electroCore Announces Publication Of New Clinical Findings For Quell Device, A Wearable Stimulation Device For The Treatment Of Fibromyalgia
electroCore, Inc. (ECOR) Q1 2026 Earnings Call Transcript
electroCore Affirms FY2026 Sales Guidance of $41.642M vs $41.957M Est
electroCore Q1 EPS $(0.59) Misses $(0.51) Estimate, Sales $9.584M Beat $9.012M Estimate
electroCore Begins Patient Enrollment In gammaCore nVNS Treatment For PTSD Study
electroCore Announces Publication in Frontiers in Neuroscience Highlighting Benefits of Non-Invasive Vagus Nerve Stimulation in Patients with Mild Traumatic Brain Injury and PTSD
electroCore Announces New Clinical Findings Published That Demonstrates Potential Benefits Of Adjunctive Non-invasive Vagus Nerve Stimulation In Patients With Chronic Mild Traumatic Brain Injury And Comorbid Post-traumatic Stress Disorder
electroCore Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
electroCore Expands Intellectual Property Portfolio
Ecora Royalties PLC Announces Director Transactions, Treasury & Voting Rights
electroCore Announces Issuance Of Two New Additions To U.S. Patent Portfolio
Ecora Royalties PLC Just Recorded A 225% EPS Beat: Here's What Analysts Are Forecasting Next
Ecora Resources H2 Earnings Call Highlights
Ecora Royalties PLC Announces Full Year Results
Ecora Royalties hails 'landmark' year as critical minerals come to the fore
electroCore Inc (ECOR) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ...
electroCore, Inc. Q4 2025 Earnings Call Summary
electroCore (ECOR) Q4 2025 Earnings Transcript
electroCore Q4 Earnings Call Highlights
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.